The Relationship Between oxLDL and CVD

Saturday October 19, 2019

Cardiovascular disease (CVD), a condition that is caused by inflammation, is the leading cause of death in the United States. CVD often leads to heart attacks, chest pain (angina), or stroke. Oxidized low-density lipoprotein (oxLDL) is a harmful type of cholesterol the accelerates inflammatory diseases, such as CVD. By targeting oxLDL, Abcentra aims to create better results for patients with CVD.

oxidized lipoprotein and cardiovascular disease

Visit Our Science page to learn more about how Abcentra’s lead candidate, orticumab, is able to target oxLDL to treat the underlying cause of CVD and other inflammatory diseases.